Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B-cell development and maturation

C M Rudin1, C B Thompson

  • 1Gwen Knapp Center for Lupus and Immunology Research, the Department of Medicine, Howard Hughes Medical Institute, University of Chicago, IL 60637, USA.

Seminars in Oncology
|September 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026
Same author

Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Lung cancer research and treatment: global perspectives and strategic calls to action.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer.

ESMO open·2023
Same author

APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

This review explores normal B-cell development, including maturation, activation, and death. It highlights key factors regulating B-cell progression and their role in B-cell malignancies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Non-Hodgkin's lymphomas often originate from B-lineage cells (approx. 85%).
  • B-cell development stages are defined by molecular markers, aiding lymphoid malignancy classification.
  • Understanding B-cell ontogeny is crucial for diagnosing and treating B-cell cancers.

Purpose of the Study:

  • To review current knowledge of normal B-cell development.
  • To focus on factors regulating B-cell maturation, activation, and apoptosis.
  • To connect normal B-cell processes to lymphoid malignancies.

Main Methods:

  • Literature review of molecular markers and genetic factors.
  • Analysis of signaling pathways in B-cell development.
  • Synthesis of current research on B-cell immune responses.

Related Experiment Videos

Main Results:

  • Key factors controlling immunoglobulin gene rearrangement and expression identified.
  • Signaling from immunoglobulin gene intermediates and molecules guides early B-cell development.
  • Mechanisms regulating peripheral B-cell activation, affinity maturation, and differentiation are increasingly understood.

Conclusions:

  • Normal B-cell development, activation, and death are tightly regulated processes.
  • Dysregulation of these processes can lead to B-cell malignancies.
  • Further research into regulatory factors can inform therapeutic strategies.